Evidence map›Paper›PMID 29306353›Full record

ArticleMicrobial genomics2017

Vibrio cholerae genomic diversity within and between patients.

Inès Levade, Yves Terrat, Jean-Baptiste Leducq, Ana A Weil, Leslie M Mayo-Smith, Fahima Chowdhury, Ashraful I Khan, Jacques Boncy, Josiane Buteau, Louise C Ivers and 7 more

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Molecular insights into the genome dynamics and interactions between core and acquired genomes ofProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. ToxigenicProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Inès Levade1​Department of Biological Sciences, University of Montreal, Montreal, Quebec, Canada.
Yves Terrat1​Department of Biological Sciences, University of Montreal, Montreal, Quebec, Canada.
Jean-Baptiste Leducq1​Department of Biological Sciences, University of Montreal, Montreal, Quebec, Canada.
Ana A Weil2​Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Leslie M Mayo-Smith2​Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Fahima Chowdhury4​Center for Vaccine Sciences, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Ashraful I Khan4​Center for Vaccine Sciences, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Jacques Boncy5​National Public Health Laboratory, Ministry of Public Health and Population, Port-au-Prince, Haiti.
Josiane Buteau5​National Public Health Laboratory, Ministry of Public Health and Population, Port-au-Prince, Haiti.
Louise C Ivers3​Department of Medicine, Harvard Medical School, Boston, MA, USA.
Edward T Ryan2​Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Richelle C Charles2​Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Stephen B Calderwood2​Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Firdausi Qadri4​Center for Vaccine Sciences, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Jason B Harris2​Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Regina C LaRocque2​Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
B Jesse Shapiro1​Department of Biological Sciences, University of Montreal, Montreal, Quebec, Canada.
Massachusetts General Hospital · USUniversité de Montréal · CAHarvard University · USInternational Centre for Diarrhoeal Disease Research · BDBrigham and Women's Hospital · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ANDREW D LUSTER · 1991 to 2026
$35.3M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Immune Responses to Vibrio cholerae infection and vaccination in HaitiR01AI099243 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HARRIS, JASON B, IVERS, LOUISE C. · 2012 to 2022
$7.9M
Protecutive immunity to human cholera in BangladeshU01AI058935 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CALDERWOOD, STEPHEN B., RYAN, EDWARD T. · 2003 to 2014
$7.8M
O-Specific Polysaccharide Responses and CholeraR37AI106878 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Edward T. Ryan · 2020 to 2026
$5.1M
Innate and early B cell responses to V. choleraeR01AI103055 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HARRIS, JASON B · 2014 to 2018
$3.9M
O-Specific Polysaccharide Responses and CholeraR01AI106878 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 2014 to 2018
$3.7M
The gut microbiome and susceptibility to Vibrio choleraeK08AI123494 · NIAID · UNIVERSITY OF WASHINGTON · PI WEIL, ANA A · 2016 to 2020
$967k
O-Specific Polysaccharide Responses and CholeraR56AI106878 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 2013 to 2020
$843k
High-throughput proteomic study of protective immunity in human cholera infectionK08AI089721 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CHARLES, RICHELLE C · 2010 to 2014
$684k
CIHRNIAID NIH HHS K08 AI089721NIAID NIH HHS K08 AI123494NIAID NIH HHS R01 AI099243NIAID NIH HHS R01 AI103055NIAID NIH HHS R01 AI106878NIAID NIH HHS R37 AI106878NIAID NIH HHS R56 AI106878NIAID NIH HHS T32 AI007061NIAID NIH HHS U01 AI058935NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

Cholera is a severe, water-borne diarrhoeal disease caused by toxin-producing strains of the bacterium Vibrio cholerae. Comparative genomics has revealed 'waves' of cholera transmission and evolution, in which clones are successively replaced over decades and centuries. However, the extent of V. cholerae genetic diversity within an epidemic or even within an individual patient is poorly understood. Here, we characterized V. cholerae genomic diversity at a micro-epidemiological level within and between individual patients from Bangladesh and Haiti. To capture within-patient diversity, we isolated multiple (8 to 20) V. cholerae colonies from each of eight patients, sequenced their genomes and identified point mutations and gene gain/loss events. We found limited but detectable diversity at the level of point mutations within hosts (zero to three single nucleotide variants within each patient), and comparatively higher gene content variation within hosts (at least one gain/loss event per patient, and up to 103 events in one patient). Much of the gene content variation appeared to be due to gain and loss of phage and plasmids within the V. cholerae population, with occasional exchanges between V. cholerae and other members of the gut microbiota. We also show that certain intra-host variants have phenotypic consequences. For example, the acquisition of a Bacteroides plasmid and non-synonymous mutations in a sensor histidine kinase gene both reduced biofilm formation, an important trait for environmental survival. Together, our results show that V. cholerae is measurably evolving within patients, with possible implications for disease outcomes and transmission dynamics.

Indexed as

Genetic VariationBangladeshCholeraEvolution, MolecularGain of Function MutationGene Transfer, HorizontalGenomicsHaitiHumansLoss of Function MutationPlasmidsPoint MutationVibrio choleraeWhole Genome Sequencingbiofilmcomparative genomicshorizontal gene transferVibrio choleraewithin-host evolution

Identifiers

PMID29306353
PMCPMC5761273
OpenAlexW2951337360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.